Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acandis Credo Intracranial Stent for Unsuccessful Recanalization After Thrombectomy (ACUTE)

NCT03955835 is registered in ClinicalTrials.gov with Acandis GmbH as lead sponsor.

NCT NCT03955835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03955835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acandis Credo Intracranial Stent for Unsuccessful Recanalization After Thrombectomy (ACUTE)
Lead sponsor
Acandis GmbH
Phase
Not applicable
Overall status
Terminated
Start date
August 9, 2019
Completion date
September 22, 2021
Enrollment
27 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, intracranial stenosis